Plain-English translation of NCT07301008 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing rimegepant, a medication taken before a migraine trigger occurs, to see if it can prevent migraines from starting. The study focuses on people who know what triggers their migraines — like exercise, travel, alcohol, or stress — and want to try preventing attacks before they happen. Researchers want to learn whether taking this medication ahead of time works better than waiting for a migraine to start and then treating it.
Many people with migraines can predict when an attack might happen because they know their personal triggers. Right now, most migraine treatments are taken after a headache starts, but this medication may offer a new option: taking it before the trigger to stop the migraine before it begins.
You likely qualify if…
You likely don't qualify if…
This study takes place at one medical center (MedStar Georgetown Headache Center) and involves taking the medication before you encounter your known migraine trigger to see if it prevents an attack. You will be monitored and tracked to see how often migraines occur when you use this preventive approach. The exact schedule of visits and how long the study lasts will be explained during the screening process.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States